Objective To assess the effectiveness of postoperative feeding guidelines in reducing the incidence and severity of intestinal failure-associated liver disease (IFALD) among infants.
Conclusions Implementation of feeding guidelines reduced time to reach feeding goals, significantly reducing IFALD incidence and severity. (J Pediatr 2018; 195:140-7) . T he optimal strategy for feeding infants after intestinal procedures for primary gastrointestinal disorders is not well understood, resulting in feeding variability as well as feeding-related risks, such as necrotizing enterocolitis (NEC).
1,2 Feeding intolerance from intestinal dysmotility can be difficult to distinguish from the early signs of NEC, resulting in apprehension about feeding advancement in this fragile population. Minimal enteral nutrition volumes (<20 mL/kg/d), or "trophic feeding," with subsequent cautious enteral nutrition advancement often are used as a means to stimulate the intestine but provide minimal calories and require parenteral nutrition for adequate caloric intake. Infants exposed to prolonged parenteral nutrition are at risk of complications, including central venous catheter-associated line infection and intestinal failure-associated liver disease (IFALD). [3] [4] [5] IFALD typically manifests as cholestasis in infants. 6, 7 IFALD remains common following intestinal surgery, with an incidence ranging from 25% to 60% depending on the center, and up to 70% in infants with NEC. [8] [9] [10] For infants with intestinal failure requiring parenteral nutrition for >30-60 days, IFALD becomes a significant risk factor for chronic liver disease and the need for liver transplantation. 11 The etiology of IFALD is multifactorial and is related to prematurity, prolonged parenteral nutrition exposure, lack of enteral nutrition, and infection. Because it is often unclear in the immediate postoperative period which infants will meet criteria for intestinal failure, carefully optimizing enteral nutrition in all at-risk infants is advisable.
Historically, our institution had a high incidence of IFALD and variable feeding practices, which prompted the creation of a postoperative feeding algorithm. 12 Our objective was to determine whether adherence to feeding guidelines would shorten the time to reach enteral nutrition goals, which would in turn decrease parenteral nutrition exposure, and therefore, decrease IFALD incidence and severity, the primary outcomes of interest. Our feeding algorithm, implementation strategy, and interim success 15 months after implementation were reported previously. 
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In this study, we report our outcomes in an expanded cohort 6 years before and 3 years after implementation of the feeding guidelines.
Methods
We performed a pre-and postguideline implementation comparison. Retrospective data were collected for the preguideline cohort from January 2007 to June 2013, and prospective data were collected for the postguideline cohort from October 2013 to December 2016. Approval and waiver of consent were obtained from the institutional review board, as the feeding guidelines were implemented as standard of care in the neonatal intensive care unit (NICU). Inclusion criteria were infants <6 months old at risk of intestinal failure due to intestinal surgery, who survived to be fed enterally, and required at least 7 days of parenteral nutrition (based on our observation of early cholestasis development in some infants). The primary diagnoses were NEC, spontaneous intestinal perforation, intestinal atresia, gastroschisis, and volvulus. Infants were excluded if they had liver disease other than IFALD or if the primary surgical procedure was performed at an outside facility.
Consensus-and evidence-based guidelines were developed by our intestinal rehabilitation team and have been published previously. 13 Major changes in the guidelines, compared with previous usual care, included a greater initial postoperative enteral nutrition volume of 15-20 mL/kg/d and faster rate of feeding advancement by the same volume if there were no signs of intolerance (increased ostomy or stool output, increased emesis, increased abdominal girth of >10%, or change in vital signs). Exceptions included infants <1000 g who were not previously fed. Such infants followed another protocol prescribing 1-2 mL of feeding every 4 hours for 5 days and then subsequently followed the postoperative guidelines. Breast milk, including donor milk, was the preferred type of enteral nutrition, but formula could be used. The individualized goal caloric requirement generally ranged from 110 to 130 kcal/ kg/d and was determined by a dietician based on the patient's gestational age and growth.
Only soy-based intravenous lipid was available at our center. Parenteral nutrition lipid dosing remained the same in both study periods. The lipid dose was increased to 3 g/kg/d in all noncholestatic infants in both cohorts to meet caloric needs unless there were extenuating circumstances, such as hypertriglyceridemia. Lipids were restricted if the direct bilirubin rose to ≥2 mg/dL.
Data Collection and Metrics
Demographic and clinical/surgical data were collected from the medical record. Initial feeding data included the first date, type, route, and volume (mL/kg/d) that enteral nutrition was attempted postoperatively. Weekly data included type, volume, and percent of calories of enteral nutrition, parenteral nutrition lipid dose, weight and z score, stool output, and laboratory values. The daily volume of first postoperative feeding and rate of advancement were used to monitor adherence to guidelines.
The primary outcomes were the incidence and severity of IFALD, defined as a direct bilirubin of ≥2 mg/dL that persisted for at least 1 week in the absence of other known liver disease. 6 Mild IFALD was defined as direct bilirubin of 2-4.9 mg/dL, moderate IFALD was defined as a peak direct bilirubin 5.0-9.9 mg/dL, and severe IFALD was defined as a peak direct bilirubin ≥10 mg/dL. 14, 15 Feeding outcomes included time (days) to reach 50% enteral nutrition (>60 mL/kg/d with weaning parenteral nutrition) and 100% enteral nutrition (>120 mL/kg/d enteral nutrition with discontinuation of parenteral nutrition) from both the time of surgery and from the time of the first postoperative feeding. Other secondary outcomes included achievement of 50% enteral nutrition within 7 days (established a priori based on clinical expectation of tolerance), mortality, total number of parenteral nutrition days, culture-positive infection (blood, urine, or peritoneal fluid), NEC after postoperative feeding, length of stay, discharge weight z score, and time to resolution of IFALD if it occurred.
Statistical Analyses
A sample size of 140 (70 per group) was estimated to detect a 20% improvement in IFALD incidence with 80% power and a type 1 error rate of 5%. We had 90% power (alpha = 0.05) to detect a 20% improvement in incidence of moderatesevere IFALD.
Fisher exact tests were used to compare differences in categorical variables. Nonparametric Wilcoxon rank-sum tests were used to compare medians, and t tests were used to compare normally distributed means of continuous variables. Multivariable logistic regression was used to examine the associations between IFALD (any severity, moderate-severe, and severe) and exposure to feeding guidelines, with adjustment for clinically and statistically significant variables (from univariate analysis). A priori, diagnosis and gestational age were considered the most clinically relevant characteristics. Variables with a P value of <.1 were explored for use in the final model. Several variables were collinear and could not be used in the same model (type of surgery with diagnosis, age of surgery with diagnosis, baseline direct bilirubin with diagnosis, gestational age with birth weight). Diagnosis (NEC/parenteral nutrition, gastroschisis, atresia, and other) and prematurity (gestational age <37 weeks) were the most clinically relevant and representative of the other variables and were therefore used in the final model, along with race (white, black, and other) and sex. Model fit was evaluated with Akaike information criterion. All infants were included in the primary analysis. Missing data were assumed to be missing at random. Kaplan-Meier survival curves were used to compare times to reach events (50% enteral nutrition, 100% enteral nutrition, and resolution of IFALD) between those in the pre-and postguideline cohorts. Nonoverlapping CIs were considered significant. Significance testing also was performed via the log-rank test for equality of survivor functions. Statistical testing was 2-sided, and P values <.05 were considered statistically significant. Analyses were performed with STATA (StataCorp, 2011, Stata Statistical Software, Release 12; StataCorp LP, College Station, Texas).
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Results
In the preguideline cohort, 83 infants were included, and 81 infants were included in the postguideline cohort. Fiftyseven preguideline and 33 postguideline subjects were included in a previously published analysis. 13 Baseline characteristics of both cohorts are described in Table I . The difference in initial surgical procedures between cohorts was due to the more frequent use of peritoneal drains in infants with NEC or parenteral nutrition before resection in the postguideline cohort, compared with the more frequent ostomy use in these infants preguidelines, but the ultimate length of resection and percent residual bowel was similar between groups.
IFALD Incidence and Severity
The cumulative incidence of IFALD was lower in the postguideline cohort compared with the preguideline cohort (51 vs 71%, P = .031), as were the odds of developing IFALD (OR 0.40, P = .017), even after adjusting for diagnosis, prematurity, sex, and race ( Table II) . The adjusted odds of developing the more clinically relevant moderate-severe IFALD (direct bilirubin ≥5 mg/dL) also was reduced significantly (OR 0.28, P = .001) with guideline use. We performed a sensitivity analysis replacing diagnosis with the initial type of procedure in the multivariable analysis. The association between feeding guideline use and the outcome remains the same (OR 0.33, P = .004) ( Table III ; available at www.jpeds.com).
The median peak direct bilirubin decreased with guideline use from a baseline to 5.7 mg/dL to 2.4 mg/dL (P = .001). Among those infants who developed IFALD, resolution of IFALD by time of discharge was more likely to occur in the postguideline cohort, 66% vs 25% (P < .001). Time to resolution was also reduced among those in the postguideline cohort (Figure 1) . The median discharge direct bilirubin was 0.8 mg/ dL (0.3-1.9) in the postguideline group, compared with 2.4 mg/ dL (0.6-4.8) in the preguideline cohort (P < .001). The use of ursodiol was less among infants with IFALD in the postguideline cohort, 21 (51%) vs 42 (71%) (P = .032).
Moderate-to-severe IFALD was most commonly found in infants with NEC or parenteral nutrition. However, fewer infants in the postguideline cohort with NEC/parenteral nutrition developed moderate-to-severe IFALD, 13 (45%) vs 33 (73%) (P = .016). The median peak direct bilirubin for infants with NEC/parenteral nutrition improved from 6.7 to 3.4 (P = .006) with use of the guidelines. In the postguideline cohort, infants with these diagnoses were prone to both feeding intolerance, as well as deviations from the guidelines before documented feeding intolerance. The median peak direct bilirubin was 5.3 mg/dL (2.8-10.7) among those with guideline deviations (n = 8) vs 2.8 mg/dL (0.8-6.0, P = .008) among those without deviations (n = 21).
Feeding Outcomes and Adherence to Guidelines
Faster achievement of 50% and 100% of enteral nutrition goals was seen in the postguideline cohort compared with the preguideline cohort among those who were able to achieve these goals (Figure 2) . The time to reach 50% enteral nutrition from the start of feeds decreased from a median of 10 to 6 days in postguideline cohort (P = .020). The time to reach 100% enteral nutrition decreased from 35 days in the preguideline cohort to 21 days in the postguideline cohort (P = .035). As a measure of protocol adherence, the volume of the initial postoperative feeding increased from a median of 10 to 20 mL/kg/d (P < .001). In the postguideline cohort, only 2 infants did not tolerate the first 24 hours of enteral nutrition and had feeds held (one started at 20 mL/kg/d and one started at 10 mL/kg/ d). The odds of reaching 50% of enteral nutrition within 7 days of starting enteral nutrition were significantly greater in the postguideline cohort (Table II) , even after adjusting for diagnosis and prematurity.
Breast milk was the initial type of enteral nutrition used most frequently, ie, 80% in the postguideline cohort and 65% in the preguideline cohort (P = .011). By discharge, breast milk was used in about 40% of both cohorts (P = .635). The remainder April 2018
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of the postguideline cohort was discharged with regular (32%), hydrolysate (14%), or elemental (16%) formula. Continuous feeding was initiated more frequently in the postguideline cohort, 51% vs 32% (P = .022). The mode of feeding (bolus vs continuous) was not specified in the guidelines, and this difference is a likely reflection of provider preference and increased number of patients with gastroschisis, who are more prone to vomiting. Refeeding via mucous fistula was not common in either cohort (6 vs 11%, P = .391). Guideline deviations were defined by either using a lowerthan-recommended initial postoperative feeding volume or lack of advancement in the absence of signs of intolerance. A total of 20 infants had 1 or more deviations. There were 15 volume deviations and 12 advancement deviations. Nearly one half of the deviations (45%) occurred in the initial few months before implementation of weekly multidisciplinary rounds. The other deviations occurred at sporadic time points but were most likely to occur in infants born premature with an initial diagnosis of NEC or parenteral nutrition (40% of deviations).
Other Outcomes
The adjusted odds of developing secondary outcomes for infants in the postguideline cohort also are displayed in Table II . Seven infants in the postguideline cohort and 4 infants in the preguideline cohort developed postoperative NEC (P = .364). The original diagnoses were parenteral nutrition (n = 4), NEC (n = 3), atresia (n = 2), gastroschisis (n = 1), and meconium ileus (n = 1). Medical NEC (stage II) occurred in 7 (63%) infants, and 4 infants (36%) developed surgical NEC (stage III). Fewer infants in the postguideline cohort had a positive blood, Figure 2 . A, The time to reach 50% enteral nutrition was shorter in the postguideline cohort (P < .001). B, The time to reach 100% enteral nutrition was shorter in the postguideline cohort (P < .001). EN, enteral nutrition.
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urine, or peritoneal culture. Three infants in each cohort had a positive culture around the time of surgery. All of the other positive cultures occurred at least 1 week after surgery.
The total days of parenteral nutrition use were decreased in the postguideline cohort, 29 days (17-65) vs 52 days (18-99, P = .037). The number of infants who were discharged home on parenteral nutrition was 5 (6%) in the postguideline cohort and 12 (14%) in the preguideline cohort (P = .122). The median lipid dose was 3 g/kg/d in the early postoperative period in both the pre-and postguideline cohorts (IQR 2-3 and 2.5-3, respectively; P = .08). Of the 100 infants who developed IFALD, 92% (92%) underwent lipid restriction within the week following diagnosis. The average lipid dose the week following the onset of cholestasis was 1.7 g/kg/d (±0.11) in the preguideline cohort and 1.2 g/kg/d (±0.12) in the postguideline cohort (P = .005).
Length of stay was similar between cohorts (57 days vs 80 days [33-124]; P = .145), even when stratified by prematurity. In a subanalysis by diagnosis, there was a significantly shorter length of stay only among those with gastroschisis, 50 (27-66) days vs 95 (66-139) days (P = .008). Weight gain was similar in both cohorts, with a median discharge weight z score of −1.0 (−1.7 to 1.2) in the post-guideline cohort and −1.4 (−2.0 to 1.3) in the preguideline cohort (P = .052). Weight z scores of <−2.0 represent the bottom fifth percentile. Nineteen infants (23%) had a discharge weight z score <−2.0 (range −5.1 to −2.1) before the guidelines, compared with 9 (11%) in the postguideline cohort. Both mortality (3 vs 4; P = .718) and need for intestinal transplant referral (1 vs 1; P = 1.000) were relatively rare and similar between cohorts.
Missing Data
Baseline direct bilirubin, but not total bilirubin, was missing from 17 infants (10%). The baseline direct bilirubin was highly correlated with the diagnosis (the more clinically relevant variable). Direct bilirubin was therefore not included in the final analysis, and missing values did not affect the analysis. Missing feeding data from the preguideline cohort included 4 infants (5%) without the date of postoperative enteral nutrition initiation, 30 infants (36%) without the first postoperative enteral nutrition volume, and 26 infants (31%) without the known date to reach 50% enteral nutrition. Discharge growth measures were missing from 7 (8%) in the preguideline cohort.
Discussion
IFALD remains a common complication in infants following intestinal surgery. The diagnosis of IFALD includes a wide range of direct bilirubin values, and the clinical significance of IFALD is associated with cholestasis severity. Infants with more severe cholestasis are at greater risk of chronic liver disease and ultimately at a greater risk of needing liver transplantation, particularly if parenteral nutrition cannot be discontinued. 11, 16 Optimizing enteral nutrition reduces the risk of IFALD, and feeding guidelines offer a systematic approach to feeding by reducing variability. After implementing postoperative feeding guidelines in our NICU, we have seen faster achievement of enteral feeding goals and reduced frequency and severity of IFALD.
The odds of developing at least moderately severe IFALD, a more clinically germane complication, were reduced by 72% in the postguideline cohort compared with the preguideline cohort, and this difference remained significant with adjustment for diagnosis and prematurity. Severe cholestasis was rare in the postguideline cohort. Infants in the postguideline cohort who did develop IFALD were more likely to have resolution of cholestasis before discharge and resolution occurred more quickly compared with the preguideline cohort.
Feeding guidelines are becoming common in the NICUs to balance the benefits of enteral nutrition with the risk of NEC in high-risk infant populations. 17, 18 Minimal enteral nutrition regimens (trophic feeding) often are used in high-risk patients; however, broad ranges in trophic volumes (5-20 mL/ kg/d) make studies of feeding practices difficult to compare to determine the ideal volume and duration of minimal enteral nutrition. 19 A study of infants born premature showed early feeding (within 48 hours of birth) improved feeding tolerance and decreased exposure to parenteral nutrition without an increase in NEC. 20 In infants with very low birth weight or congenital heart disease, both at greater risk for NEC, feeding protocols resulted in faster achievement of enteral nutrition goals without increased NEC. [21] [22] [23] The American Society for Parenteral & Enteral Nutrition found sufficient evidence to support early initiation of enteral nutrition and advancing by 30 mL/ kg/d in infants who did not undergo surgery at risk for NEC. 24 For infants who did undergo surgery, a recent systematic review found improved outcomes in general when care was provided by multidisciplinary intestinal rehabilitation team focused on nutrition support, but best practices for postoperative feeding have not yet been determined. 25 The ideal "minimum" volume of enteral nutrition needed to offer protection from IFALD in infants undergoing surgery is not known. In our preguideline cohort, infants were routinely kept on prolonged trophic volumes of enteral nutrition (<20 mL/kg/d), and the incidence of IFALD was 70%. The incidence of moderate-to-severe cholestasis was 56%. In devising the guidelines, we hypothesized that 50% enteral nutrition would be more protective against IFALD than trophic volumes. This goal volume was based on anticipated clinical tolerance, ability to wean parenteral nutrition calories at this volume, and our previous data suggesting protection from IFALD among infants fed more quickly. Although the study does encompass a heterogeneous group of infants, we believe the general principles for initiation and early advancement of enteral nutrition are applicable to most infants with intestinal surgery. Nearly all infants tolerated an initial postoperative feeding volume of 20 mL/kg/d and were able to tolerate daily advancement of 20 mL/kg/d up to 60-80 mL/kg/d (50% of goal enteral nutrition volume), even among infants <1000 g. The ability to advance enteral nutrition beyond 50% of goal calories was highly individualized and affected by motility, malabsorption, and other comorbidities that affect critically ill infants.
The incidence of NEC in the postoperative period was monitored as a potential adverse event of enteral feeding. NEC occurs in 2%-7% of NICU admissions, most commonly in infants born preterm. 26, 27 NEC recurs in 10% of infants. 26, 28 NEC has also been reported in 10%-20% of infants with gastroschisis. 29 Careful monitoring with all feeding advancement is therefore necessary. Although not statistically different from the preguideline cohort or national norms, 7 cases of NEC occurred after postoperative feeding in the postguideline cohort, 3 of which were fatal. The overall mortality was not different between cohorts (4% vs 5%). One such infant with NEC totalis was not being fed at the time, and 2 infants had already achieved 100% enteral nutrition volume with fortification to 22 kcal/ oz. Our guidelines do not specifically give recommendations for fortification, but a hydrolysate formula frequently was used. Strategies for fortification in infants at risk of NEC are currently debated in the literature without clear best practices. 30 Other factors also may have affected the severity of IFALD in our study, including the reduced infection rate in the postguideline cohort. The difference in infection (positive culture in blood, urine, or peritoneal fluid) between cohorts is likely multifactorial. Attention to central line care has improved in recent years. In addition, improved enteral nutrition promotes intestinal mucosal barrier function, thereby reducing intestinal bacterial translocation and reducing the risk of infection. 31, 32 Faster achievement of enteral nutrition allows for sooner discontinuation of parenteral nutrition and the central catheter, also reducing risk. A potential modifying effect on IFALD severity cannot be entirely excluded, as infection can also cause elevation of bilirubin.
The limitations of the study include a relatively small sample size to adjust for potential confounders, and the data are from a single center. As the result of chance, there was heterogeneity in diagnoses between cohorts, although not statistically significant. Gestational age and birth weight were very similar between cohorts. Our baseline IFALD risk was greater than the incidence reported at other centers. Nonetheless, we have seen continued improvement in outcomes once guideline adherence was achieved. Infants with intestinal failure typically require parenteral nutrition for at least 30 days; however, we included all infants with at least 7 days of parenteral nutrition as we have observed early development of cholestasis within 10 days in some infants. We also were suspicious that not all infants with prolonged parenteral nutrition use in the preguideline cohort truly had a prolonged parenteral nutrition requirement due to feeding intolerance, but rather feeding advancement was not attempted. The median total parenteral nutrition use was just <30 days in the postguideline cohort, and we believe that without the feeding guidelines those infants would have been on parenteral nutrition for a longer period of time, making them appear "sicker." There were a similar number of subjects in each cohort who received parenteral nutrition for <14 days (15 subjects in the preguideline cohort and 13 in postguideline cohort). Overall, the length of resection in both cohorts was relatively short. In a cohort of only infants with more substantial resection, the results of the feeding intervention may not be the same. Further studies are in progress with another site to test the generalizability of the guidelines and will allow for further risk stratification by diagnosis and other risk factors. As we collect more data, more refined strategies for enteral nutrition advancement also are expected to emerge.
In conclusion, our postoperative feeding guidelines have been well tolerated. Guideline use has resulted in shorter times to initiate postoperative enteral nutrition and reach 50% of the goal enteral nutrition volume. With faster achievement of enteral nutrition goals, we have seen a significant reduction in both overall IFALD incidence, as well as IFALD severity. ■ 
